Clendeninn Neil James 4
4 · ONCOGENEX PHARMACEUTICALS, INC. · Filed Oct 19, 2012
Insider Transaction Report
Form 4
Clendeninn Neil James
Director
Transactions
- Exercise/Conversion
Common Stock
2012-10-18$4.11/sh+513$2,106→ 7,562 total - Exercise/Conversion
Stock Option
2012-10-18−513→ 0 totalExercise: $4.11From: 2006-03-23Exp: 2013-03-23→ Common Stock (513 underlying)